Thank you to the Biden Administration for dropping the new changes to Medicare that would have put people living with cancer, mental illness, HIV, organ transplants, and epilepsy at risk!
Background on TRUMP Medicare Changes : On January 19, 2021, the Center for Medicare and Medicaid Innovation (CMMI) launched the PDM Model to test a new Part D design voluntarily. The changes include removing protections for the six protected classes.
As of CY2022, participating Part D sponsors would be permitted to treat only five of the six protected classes- anticonvulsants, immunosuppressants, antidepressants, antipsychotics, and antineoplastics as they would other Part D drugs. As of CY 2023, CMS intends to remove protections for the sixth protected class – antiretrovirals.
Furthermore, as of CY 2022, regarding all other classes of drugs aside from the six protected classes, participating Part D sponsors would be permitted to include only one drug per drug class on their formulary rather than a minimum of two drugs per class, as is currently required. As a result, many patients who require multiple medications within the six protected classes may lose access to their most needed drugs.
AS of March 16, 2021- these changes have been stopped! Thank you to the Biden Administration and members of Congress, including Oregon’s Representative Bonamici, for your leadership in protecting patients.